Investor Presentaiton slide image

Investor Presentaiton

Unwavering Regulatory and Quality foundation Laurus Philosophy "One Quality Standard for All Markets" Facility Regulatory Certifications Year started Last US FDA- Inspection status No of USFDA audits (since inception) 91 Total Regulatory Audits Kilo Lab - R&D USFDA, TGA, KFDA, PMDA, ANVISA Brazil 2008 2021 USFDA 4 1,025+ 935+ Unit 1 USFDA, TGA, MHRA-UK, KFDA, WHO-Geneva, PMDA, NIP-Hungary, Russian GMP, Mexican, ANVISA 2008 2019 EIR Received 6 44 Audits/6 Global Quality audits since inception Customer audits USFDA, BGV-Hamburg, WHO- Regulators (USFDA/WHO/PMDA/TGA/EMA/M HRA) Geneva, ZAZIBONA, Tanzania-FDA, NDA-Uganda, PMPB-Malawi, KENYA, Unit 2 2016 2023- EIR Received LO 5 MCAZ-Zimbabwe, JAZMP-Slovenia, Ethiopia-FDA, Kazakhstan, EMA, MFDS-Korea, Malta-MA USFDA, WHO-Geneva, NIP- Unit 3 Hungary, Russian GMP, Mexican, JAZMP-Slovenia, KFDA, ANVISA 2015 2019 EIR received 4 On-going improvement in QMS and implementation across different functions, incl. R&D, Quality and Technical operations Unit 4 WHO-Geneva, USFDA & Mexican 2018 - 2019 EIR received 1 Unit 5 USFDA 2017 2022 EIR received 1 ■ No incidents of Product Recall in the last five years Unit 6 USFDA 2018 2018 EIR received 1 ■ #51 Quality audits in H1: Regulatory #4 & Customer #47 Sriam Labs None 2018 Nil Nil LSPL U-1 None 2020 Nil Nil 11 Laurus Q2 & H1 FY 2024 Investor Presentation | October 20, 2023 LAURUS Labs Knowledge Innovation. Excellence
View entire presentation